Dr. Samuel Mcclure, M.D

NPI: 1750407680
Total Payments
$209.64
2019 Payments
$15.85
Companies
5
Transactions
12

Payment Breakdown by Category

Food & Beverage$209.64 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $209.64 12 100.0%

Top Paying Companies

Company Total Records Latest Year
Shire North American Group Inc $117.21 7 $0 (2019)
Allergan Inc. $35.00 1 $0 (2017)
Tris Pharma Inc $25.77 2 $0 (2018)
Sunovion Pharmaceuticals Inc. $16.37 1 $0 (2018)
Vertical Pharmaceuticals, LLC $15.29 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2019 $15.85 1 Shire North American Group Inc ($15.85)
2018 $96.19 6 Shire North American Group Inc ($50.85)
2017 $97.60 5 Shire North American Group Inc ($50.51)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/07/2019 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $15.85 General
Category: NEUROSCIENCE
11/14/2018 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $14.85 General
Category: NEUROSCIENCE
10/03/2018 Tris Pharma Inc Dyanavel XR (Drug) Food and Beverage In-kind items and services $13.68 General
Category: ADHD
08/30/2018 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $18.64 General
Category: NEUROSCIENCE
07/19/2018 Vertical Pharmaceuticals, LLC METHYLPHENIDATE 72 (Drug), LORZONE Food and Beverage In-kind items and services $15.29 General
Category: ADHD
06/28/2018 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $17.36 General
Category: NEUROSCIENCE
06/20/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $16.37 General
Category: CNS
12/07/2017 Shire North American Group Inc MYDAYIS (Drug) Food and Beverage In-kind items and services $15.60 General
Category: NEUROSCIENCE
11/28/2017 Tris Pharma Inc Dyanavel XR (Drug) Food and Beverage In-kind items and services $12.09 General
Category: ADHD
10/20/2017 Shire North American Group Inc MYDAYIS (Drug) Food and Beverage In-kind items and services $19.45 General
Category: NEUROSCIENCE
06/13/2017 Allergan Inc. NATRELLE 410 IMPLANTS (Device) Food and Beverage In-kind items and services $35.00 General
Category: PLASTICS
05/25/2017 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $15.46 General
Category: NEUROSCIENCE

About Dr. Samuel Mcclure, M.D

Dr. Samuel Mcclure, M.D is a Psychiatry healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1750407680.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Mcclure, M.D has received a total of $209.64 in payments from pharmaceutical and medical device companies, with $15.85 received in 2019. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($209.64).

Practice Information

  • Specialty Psychiatry
  • Location Orlando, FL
  • Active Since 03/22/2007
  • Last Updated 07/08/2007
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1750407680

Products in Payments

  • VYVANSE (Drug) $82.16
  • MYDAYIS (Drug) $35.05
  • NATRELLE 410 IMPLANTS (Device) $35.00
  • Dyanavel XR (Drug) $25.77
  • LATUDA (Drug) $16.37
  • METHYLPHENIDATE 72 (Drug) $15.29

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Orlando